Novo Nordisk A/S
NOVO-B
Κατάταξη σε μετοχές
#109
Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the... Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
Τιμή μετοχής
$39.24
Κεφαλαιοποίηση
$173.16B
Αλλαγή (1 ημέρα)
-5.26%
Αλλαγή (1 έτος)
-28.83%
Χώρα
DK
Εμπόριο Novo Nordisk A/S (NOVO-B)
Κατηγορία
Healthcare
Ιστορικό μερισμάτων για Novo Nordisk A/S (NOVO-B)
Η μετοχή Novo Nordisk A/S (σύμβολο: NOVO-B) κατέβαλε συνολικά 35 μερίσματα.
Το συνολικό ποσό των μερισμάτων (προσαρμοσμένο για διασπάσεις μετοχών) είναι: $72.55
Απόδοση μερίσματος (TTM): 0.0375
Το συνολικό ποσό των μερισμάτων (προσαρμοσμένο για διασπάσεις μετοχών) είναι: $72.55
Απόδοση μερίσματος (TTM): 0.0375
Καταβολές μερισμάτων για Novo Nordisk A/S (NOVO-B) από 2001 έως 2026
Ετήσιες καταβολές μερισμάτων
| Έτος | Μέρισμα (προσαρμοσμένο για διασπάσεις μετοχών) | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $3.75 | -67.81% |
| 2025 | $11.65 | 17.68% |
| 2024 | $9.90 | 39.93% |
| 2023 | $7.08 | 26.91% |
| 2022 | $5.58 | 19.25% |
| 2021 | $4.68 | 8.72% |
| 2020 | $4.30 | 5.52% |
| 2019 | $4.08 | 3.82% |
| 2018 | $3.93 | 3.29% |
| 2017 | $3.80 | -19.15% |
| 2016 | $4.70 | 88.00% |
| 2015 | $2.50 | 11.11% |
| 2014 | $2.25 | 25.00% |
| 2013 | $1.80 | 28.57% |
| 2012 | $1.40 | 40.00% |
| 2011 | $1.00 | 33.33% |
| 2010 | $0.75 | 25.00% |
| 2009 | $0.6 | 33.33% |
| 2008 | $0.45 | 28.57% |
| 2007 | $0.35 | 16.67% |
| 2006 | $0.3 | 25.00% |
| 2005 | $0.24 | 9.09% |
| 2004 | $0.22 | 22.22% |
| 2003 | $0.18 | 7.46% |
| 2002 | $0.1675 | -74.72% |
| 2001 | $0.6625 | 0.00% |
Λίστα όλων των καταβολών μερισμάτων
| Έτος | Μέρισμα | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $3.75 | -67.81% |
| 2025 | $11.65 | 17.68% |
| 2024 | $9.90 | -30.04% |
| 2023 | $14.15 | 26.91% |
| 2022 | $11.15 | 19.25% |
| 2021 | $9.35 | 8.72% |
| 2020 | $8.60 | 5.52% |
| 2019 | $8.15 | 3.82% |
| 2018 | $7.85 | 3.29% |
| 2017 | $7.60 | -19.15% |
| 2016 | $9.40 | 88.00% |
| 2015 | $5.00 | 11.11% |
| 2014 | $4.50 | -75.00% |
| 2013 | $18.00 | 28.57% |
| 2012 | $14.00 | 40.00% |
| 2011 | $10.00 | 33.33% |
| 2010 | $7.50 | 25.00% |
| 2009 | $6.00 | 33.33% |
| 2008 | $4.50 | -35.71% |
| 2007 | $7.00 | 16.67% |
| 2006 | $6.00 | 25.00% |
| 2005 | $4.80 | 9.09% |
| 2004 | $4.40 | 22.22% |
| 2003 | $3.60 | 7.46% |
| 2002 | $3.35 | -94.94% |
| 2001 | $66.25 | 0.00% |
Καταβολές μερισμάτων για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Αριθμός καταβολών μερισμάτων | Χώρα |
|---|---|---|
| 217.00% |
US
|
|
| 228.00% |
US
|
|
| 56.00% |
US
|
|
| 225.00% |
US
|
|
| 33.00% |
CH
|
